These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1287139)

  • 1. AIDS patients with bacterial lower respiratory tract infections: treatment with ofloxacin versus sulbactam-ampicillin.
    De Simone C; Trinchieri V; Tzantzoglou S; Famularo G; Moretti S; Delia S
    J Chemother; 1992 Dec; 4(6):376-80. PubMed ID: 1287139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with sulbactam/ampicillin in the pediatric field].
    Sekiguchi T; Okamoto T; Ohara K; Kohzan S; Nishimori M; Miyazaki M
    Jpn J Antibiot; 1989 Mar; 42(3):733-42. PubMed ID: 2746853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
    Lode H
    Int J Antimicrob Agents; 2001 Sep; 18(3):199-209. PubMed ID: 11673031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
    Dajani A
    J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of an ampicillin/sulbactam combination in respiratory infections].
    Mangiarotti P; Manara G; Grassi G; Gialdroni Grassi G
    G Ital Chemioter; 1989; 36(1-3):39-44. PubMed ID: 2488911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sulbactam/ampicillin and sultamicillin in the treatment of bacterial infections of the upper respiratory tract of children.
    Bluestone CD
    APMIS Suppl; 1989; 5():35-40. PubMed ID: 2660869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
    De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
    J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampicillin/sulbactam in lower respiratory tract infections: a review.
    Cunha BA
    Clin Ther; 1991; 13(6):714-26. PubMed ID: 1790546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of sulbactam/ampicillin in the pediatric infections].
    Meguro H; Arimasu O; Shiraishi H; Sugamata K; Hiruma F; Abe T; Fujii R; Mashiko J; Nagao Y; Okamoto Y
    Jpn J Antibiot; 1989 Mar; 42(3):612-22. PubMed ID: 2746845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on sulbactam/ampicillin in the pediatric field].
    Takeda E; Hosoda T; Ichioka T; Miyao M
    Jpn J Antibiot; 1989 Mar; 42(3):725-31. PubMed ID: 2746852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
    McKinnon PS; Neuhauser MM
    Pharmacotherapy; 1999 Jun; 19(6):724-33. PubMed ID: 10391418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide clinical experience with sultamicillin.
    Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
    APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulbactam/ampicillin in the treatment of lower respiratory infections.
    Castellano MA
    Drugs; 1988; 35 Suppl 7():53-6. PubMed ID: 3065054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of lower respiratory tract infections with sultamicillin.
    Tageldin MA; Said A
    J Int Med Res; 1992; 20 Suppl 1():44A-52A. PubMed ID: 1451929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections.
    Scalambrino S; Mangioni C; Milani R; Regallo M; Norchi S; Negri L; Carrera S; Vigano EF; Ruffilli MP; Canale MP
    Suppl Int J Gynecol Obstet; 1989; 2():21-7. PubMed ID: 2679680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.